Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.676 EUR | +1.09% | +0.72% | -63.57% |
12.06. | Phaxiam: Kapitalerhöhung um zehn Millionen Euro | CF |
15.04. | Phaxiam: Beginn der Studie zur infektiösen Endokarditis | CF |
5-Tages-Kurse: PHAXIAM Therapeutics S.A.
Schlusskurs Euronext Paris09.09.2024 | 10.09.2024 | 11.09.2024 | 12.09.2024 | 13.09.2024 | |
---|---|---|---|---|---|
Kurs | 1.688 € | 1.682 € | 1.658 € | 1.676 € | 1.65 € |
Volumen | 7 238 | 990 | 4 051 | 3 082 | 2 181 |
Veränderung | +1.44% | -0.36% | -1.43% | +1.09% | -1.55% |
Eröffnung | 1.690 € | 1.688 € | 1.682 € | 1.650 € | 1.642 € |
Hoch | 1.690 € | 1.688 € | 1.682 € | 1.676 € | 1.668 € |
Tief | 1.652 € | 1.654 € | 1.650 € | 1.640 € | 1.640 € |
Performance
1 Tag | +1.09% | ||
1 Woche | +0.72% | ||
Aktueller Monat | -0.24% | ||
1 Monat | -6.89% | ||
3 Monate | -20.19% | ||
6 Monate | -41.81% | ||
Laufendes Jahr | -63.57% | ||
1 Jahr | -60.28% | ||
3 Jahre | -96.67% | ||
5 Jahre | -96.58% | ||
10 Jahre | -99.01% |
Volumen
MärkteBasisdaten
Indikatoren
Zu einer Liste hinzufügen 0 ausgewählt | % | % 5 Tage | % 1 Jahr | Veränd. 3 J. | Kap. ($) | |
---|---|---|---|---|---|---|
+1.09% | +0.72% | -60.28% | -96.67% | 18.26 Mio. | ||
+1.40% | +3.71% | +39.11% | +157.00% | 125 Mrd. | ||
-0.95% | +1.93% | +40.07% | +76.89% | 124 Mrd. | ||
+0.41% | +0.08% | -0.47% | +79.41% | 32.35 Mrd. | ||
+17.52% | +37.20% | +9.15% | -65.26% | 29.34 Mrd. | ||
+16.49% | +160.23% | +1’607.49% | +395.81% | 23.47 Mrd. | ||
+1.13% | +3.75% | -0.91% | -47.12% | 21.1 Mrd. | ||
+1.18% | -3.23% | -32.53% | -33.38% | 16.98 Mrd. | ||
+0.15% | +2.63% | -50.10% | -71.90% | 16.01 Mrd. | ||
+1.64% | +3.96% | +124.28% | +338.56% | 14.35 Mrd. | ||
Durchschnitt | +4.01% | +20.94% | +167.58% | +73.33% | 40.34 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | +2.58% | +14.02% | +119.66% | +102.45% |
Vergangene Kurse: PHAXIAM Therapeutics S.A.
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen | Veränderung |
---|
Kurs-Extreme
Monatliche Veränderungen
Jährliche Veränderungen
2024 | -64.13% | ||
2023 | +25.41% | ||
2022 | -82.70% | ||
2021 | -70.18% | ||
2020 | +6.12% | ||
2019 | +7.20% | ||
2018 | -66.22% | ||
2017 | +34.64% | ||
2016 | -46.37% | ||
2015 | -5.39% | ||
2014 | +172.43% | ||
2013 | -13.41% |
- Börse
- Aktien
- A3EJH8 Aktie
- Kurse PHAXIAM Therapeutics S.A.
MarketScreener is also available in this country: United States.
Switch edition